Nurse personal experience + 32 trials (1505 patients) treated with LLLT for Oral mucositis presented at Oncology Nursing conference, read full article on PracticeUpdate.
April 23, 2015–Orlando, Florida–Low-level laser therapy has been shown to reduce the incidence and severity of oral mucositis significantly in patients undergoing chemoradiotherapy for head and neck cancer or stem cell transplantation. This result of an analysis of 32 prospective trials including 1505 patients was presented at the 40th Annual Oncology Nursing Symposium from April 23 – 26 in Orlando, Florida.
Annette Quinn, RN, MSN, of the University of Pittsburgh Cancer Institute, explained that oral mucositis is one of the most debilitating toxicities of cancer therapy. Nearly all patients with head and neck tumors treated with chemoradiotherapy, and 75% of those undergoing stem cell transplantation with total body irradiation experience some degree of oral mucositis. “Over the last decade,” said Ms. Quinn, “the prevalence of oral mucositis has risen due to new chemotherapy, the introduction of targeted agents, and the delivery of higher doses of radiation.”
Source: Low-Level Laser Therapy Reduces the Incidence and Severity of Oral Mucositis | PracticeUpdate